In addition to renal VEGFR1 expression, many conditions involving neovascularization, such as atherosclerosis, stroke, and osteoarthritis, can provide a false positive when imaging tumor VEGFR, especially in the brain and bones, which are frequent sites of breast cancer metastasis. This evidence concerns the gene FLT1 and breast cancer.